Angiotensin II-induced tyrosine phosphorylation in mesangial and vascular smooth muscle cells

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 1, 1996, Pages 83-88

  Marrero, Mario B ^a   Schieffer, Bernhard ^a   Bernstein, Kenneth E ^a   Ling, Brian N ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Calcium channels; Chloride channels; Contraction; Growth; Mesangial cells; Tyrosine kinase; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; CHLORIDE CHANNEL; TYROSINE;

ANIMAL; AORTA; DRUG EFFECT; MESANGIUM; METABOLISM; PHOSPHORYLATION; RAT; REVIEW; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA; CHLORIDE CHANNELS; GLOMERULAR MESANGIUM; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RATS; TYROSINE;

EID: 0029690845     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb03067.x     Document Type: Conference Paper

References (46)

1. Fogo A, Yoshida A, Glick AD, Homma T, Ichikawa I. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J. Clin. Invest. 1988; 82: 322-30.
2. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I. Effects of antihypertensive drugs on glomerular morphology. Kidney Int. 1989; 36: 626-35.
3. Tolins JP, Raij L. Angiotensin converting enzyme inhibitors and progression of chronic renal failure. Kidney Int. 1990; 38: S118-22.
4. Johnson RJ, Alders CE, Yoshimura et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464-74.
5. Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J. Am. Soc. Nephrol. 1993; 3: 1531-40.
6. Douglas JG, Hopfer U. Novel aspect of angiotensin receptors and signal transduction in the kidney. Annu. Rev. Physiol. 1994; 56: 649-69.
7. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γ1 in vascular smooth muscle cells. J. Biol. Chem. 1994; 269: 10935-9.
8. Timmermans PB, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 1993; 45: 205-51.
9. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type 1 angiotensin II receptor. Nature 1991; 351: 233-6.
10. Alexander RW, Brock TA, Gimbrone MA, Rittenhouse SL. Angiotensin II increases inositol triphosphate and calcium in vascular smooth muscle cells. Hypertension 1985; 7: 447-51.
11. Cockcroft S, Thomas GMH. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem. J. 1992; 288: 1-14.
12. Homma Y, Sakamoto H, Tsunoda M, Aoki M, Takenawa T, Ooyama T. Evidence for involvement of phospholipase C-γ2 in signal transduction of platelet-derived growth factor in vascular smooth muscle cells. Biochem. J. 1993; 290: 649-53.
13. Akiyama T, Ogawara H. Use and specificity of genistein as inhibitor of tyrosine phosphorylation. Methods Enzymol. 1991; 201: 362-70.
14. Gordon JA. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 1991; 201: 477-82.
15. Barnett RL, Ruffini L, Ramsammy L, Pasmantier R, Friedlaender MM, Nord EP. Angiotensin-mediated phosphatidylcholine hydrolysis and protein kinase C activation in mesangial cells. Am. J. Physiol. 1993; 265: C1100-8.
16. Force T, Kyriakis JM, Avruch J, Bonventre JV. Endothelin, vasopressin and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. J. Biol. Chem. 1991; 266: 6650-6.
17. - channels in glomerular mesangial cells. Am. J. Physiol. 1995; (in press).
18. 2+, PKC and G proteins. Am. J. Physiol. 1992; 262: F668-78.
19. Kurokawa K. Chloride conductance of mesangial cells. Renal Physiol. Biochem. 1993; 16: 15-20.
20. Ling BN, Seal EE, Eaton DC. Regulation of mesangial cell ion channels by insulin and angiotensin II: Possible role in diabetic glomerular hyperfiltration. J. Clin. Invest. 1993; 92: 2141-51.
21. Ling BN, Matsunaga H, Ma H, Eaton DC. Role of growth factors in mesangial cell ion channel regulation. Kidney Int. 1995 (in press).
22. Seal EE, Eaton DC, Gomez LM, Ma H, Ling BN. Extracellular glucose reduces mesangial cell ion channel responsiveness to angiotensin II. Am. J. Physiol. 1995 (in press).
23. Klockner U. Intracellular calcium ions activate a low-conductance chloride channel in smooth-muscle cells isolated from human mesenteric artery. Pflugers Arch. 1993; 424: 231-7.
24. Ling BN. High glucose reduces the responsiveness of mesangial cell (MC) ion channels to angiotensin II (AII), despite the presence of insulin. Clin. Res. 1994; 42: 114A (abstract).
25. Inoue R, Waniishi Y, Yamada K, Ito Y. A possible role of tyrosine kinases in the regulation of muscarinic receptor-activated cation channels in guinea pig ileum. Biochem. Biophys. Res. Commun. 1994; 203: 1392-7.
26. Matsumoto PS, Ohara A, Duchatelle P, Eaton DC. Tyrosine kinase regulates epithelial sodium transport in A6 cells. Am. J. Physiol. 1993; 264: C246-50.
27. Minami K, Fukuzawa K, Inoue I. Regulation of a non-selective cation channel of cultured porcine coronary artery smooth muscle cells by tyrosine kinase. Pflugers Arch. 1994; 426: 254-7.
28. Malloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 1993; 268: 7338-45.
29. Huckle WR, Prokop CA, Dy RC, Herman B, Earp S. Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner. Mol. Cell Biol. 1990; 10: 6290-8.
30. Tsuda T, Kawahara Y, Shii K, Koide M, Ishida Y, Yokoyama M. Vasoconstrictor induced protein-tyrosine phosphorylation in cultured rat vascular smooth muscle cells. FEBS Lett. 1991; 285: 44-8.
31. Butcher RD, Schollmann C, Marme D. Angiotensin II mediates intracellular signalling in vascular smooth muscle cells by activation of tyrosine-specific protein kinases and c-raf-1. Biochem. Biophys. Res. Commun. 1993; 196: 1280-7.
32. Laniyonu AA, Saifeddine M, Yang S-G, Hollenberg MD. Tyrosine kinase inhibitors and the contractile actions of G-protein-linked vascular agonists. Can. J. Physiol. Pharmacol. 1994; 72: 1075-85.
33. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 1993; 268: 7338-45.
34. Granot Y, van Putten V, Schrier RW. Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human platelets. Biochem. Biophys. Res. Commun. 1990; 168: 566-73.
35. Zachary I, Gil J, Lehmann W, Sinnet-Smith J, Rozengurt E. Bombesin, vasopressin and endothelin rapidly stimulate tyrosine phosphorylation in intact Swiss 3T3 cells. Proc. Natl Acad. Sci. USA 1991; 88: 4577-81.
36. Wilkes LC, Patel V, Purkiss JR, Boarder MR. Endothelin-1 stimulated phospholipase-D in A10 vascular smooth muscle derived cells is dependent oil tyrosine kinases. Evidence for involvement in stimulation of mitogenesis. FEBS Lett. 1993; 322: 147-52.
37. Dhar A, Shukla SD. involvement of pp60c-src in platelet activating factor stimulated platelets. Evidence for translocation from cytosol to membrane. J. Biol. Chem. 1991; 266: 18797-801.
38. Dhar A, Shukla SD. Electrotransjection of pp60c-src monoclonal antibody inhibits activation of phospholipase C in platelets. J. Biol. Chem. 1994; 269: 9123-7.
39. Offermanns S, Bombien E, Schultz G. Thrombin Ca(2+)-dependently stimulates protein tyrosine phosphorylation in BC3H1 cells. Biochem. J. 1993; 290: 27-32.
40. Sargeant P, Farndale RW, Sage SO. The tyrosine kinase inhibitors methyl 2,5-dihydroxycinamate and genistein reduce thrombin evoked tyrosine phosphorylation and calcium entry in human platelets. FEBS Lett. 1993; 315: 242-6.
41. Guinebault C, Payrastre B, Sultan C et al. Tyrosine kinases and phosphoinositide metabolism in thrombin stimulated human platelets. Biochem. J. 1993; 292: 851-6.
42. Tate BF, Rittenhouse SE. Thrombin activation of human platelets causes tyrosine phosphorylation of PLC-γ1. Biochem. Biophys. Acta 1993; 1178: 281-5.
43. Marrero MB, Schieffer B, Paxton WG, Schieffer E, Bernstein KE. Electroporation of pp60c-src antibodies inhibits angiotensin II activation of phospholipase C-γ1 in rat aortic smooth muscle cells. J. Biol. Chem. 1995 (in press).
44. Liao F, Shin HS, Rhee SG. In vitro tyrosine phosphorylation of phospholipase C-γ1 and phospholipase C-γ1 by src-family protein tyrosine kinase. Biochem. Biophys. Res. Commun. 1993; 191: 1028-33.
45. 2+-permeable channel associated with platelet-derived growth factor receptor in mesangial cells. Am. J. Physiol. 1994; 267: C456-65.
46. 2+-permeable channels in mesangial cells: Activation involves a GTP-binding protein and tyrosine kinase. J. Cell. Biochem. 1994; 18B: 256.